A Study and In Vitro Evaluation of the Bioactive Compounds of Broad Bean Sprouts for the Treatment of Parkinson's Syndrome.

IF 4.2 2区 化学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Danni Hu, Guanglei Qing, Xuecheng Liu, Jianming Cheng, Kewei Zhang, Lingyun He
{"title":"A Study and In Vitro Evaluation of the Bioactive Compounds of Broad Bean Sprouts for the Treatment of Parkinson's Syndrome.","authors":"Danni Hu, Guanglei Qing, Xuecheng Liu, Jianming Cheng, Kewei Zhang, Lingyun He","doi":"10.3390/molecules29215160","DOIUrl":null,"url":null,"abstract":"<p><p>Levodopa (LD) is the first discovered and the most promising and effective medication for Parkinson's disease (PD). As the first identified natural source of LD, <i>Vicia faba</i> L. (broad beans), especially its sprouts, has been confirmed to contain many other potential bioactive compounds that could also be therapeutic for PD. In this study, the bioactive components obtained from broad bean sprout extraction (BSE) that could be beneficial for PD treatment were screened, and the related mechanisms were explored. Solvent extraction combined with column chromatography was used to isolate bioactive fractions and monomer compounds, while UPLC-ESI-MS/MS, HRESI-MS and (<sup>1</sup>H, <sup>13</sup>C) NMR were employed for compound identification. Network pharmacology techniques were applied to screen for potential mechanisms. A total of 52 compounds were identified in a 50% MeOH extract of broad bean sprouts. Moreover, twelve compounds were isolated and identified from ethyl acetate and <i>n</i>-butanol portions, including caffeic acid (1), <i>trans</i>-3-indoleacrylic acid (2), <i>p</i>-coumaric acid (3), protocatechualdehyde (4), isovitexin (5), isoquercetin (6), grosvenorine (7), kaempferol-3-O-rutinoside (8), isoschaftoside (9), narcissin (10), kaempferitrin (11) and trigonelline HCl (12). Compounds <b>2</b>, <b>4</b>, <b>7</b>, <b>8</b> and <b>12</b> were isolated from <i>Vicia faba</i> L. for the first time. The potential mechanisms were determined by analyzing 557 drug targets, 2334 disease targets and 199 intersections between them using a protein-protein interaction (PPI) network, gene ontology (GO) analysis and Kyoto encyclopedia of genes and genomes (KEGG) enrichment. Further in vitro experiments confirmed that caffeic acid (compound <b>1</b>) and <i>p</i>-coumaric acid (compound <b>3</b>) have neuroprotective effects in 6-hydroxydopamine-treated SH-SY5Y cells and lipopolysaccharide-treated PC-12 cells through anti-inflammatory and antioxidant mechanisms. In conclusion, this study explored effective components in broad bean sprouts and performed <i>in vitro</i> evaluations.</p>","PeriodicalId":19041,"journal":{"name":"Molecules","volume":"29 21","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547941/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecules","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.3390/molecules29215160","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Levodopa (LD) is the first discovered and the most promising and effective medication for Parkinson's disease (PD). As the first identified natural source of LD, Vicia faba L. (broad beans), especially its sprouts, has been confirmed to contain many other potential bioactive compounds that could also be therapeutic for PD. In this study, the bioactive components obtained from broad bean sprout extraction (BSE) that could be beneficial for PD treatment were screened, and the related mechanisms were explored. Solvent extraction combined with column chromatography was used to isolate bioactive fractions and monomer compounds, while UPLC-ESI-MS/MS, HRESI-MS and (1H, 13C) NMR were employed for compound identification. Network pharmacology techniques were applied to screen for potential mechanisms. A total of 52 compounds were identified in a 50% MeOH extract of broad bean sprouts. Moreover, twelve compounds were isolated and identified from ethyl acetate and n-butanol portions, including caffeic acid (1), trans-3-indoleacrylic acid (2), p-coumaric acid (3), protocatechualdehyde (4), isovitexin (5), isoquercetin (6), grosvenorine (7), kaempferol-3-O-rutinoside (8), isoschaftoside (9), narcissin (10), kaempferitrin (11) and trigonelline HCl (12). Compounds 2, 4, 7, 8 and 12 were isolated from Vicia faba L. for the first time. The potential mechanisms were determined by analyzing 557 drug targets, 2334 disease targets and 199 intersections between them using a protein-protein interaction (PPI) network, gene ontology (GO) analysis and Kyoto encyclopedia of genes and genomes (KEGG) enrichment. Further in vitro experiments confirmed that caffeic acid (compound 1) and p-coumaric acid (compound 3) have neuroprotective effects in 6-hydroxydopamine-treated SH-SY5Y cells and lipopolysaccharide-treated PC-12 cells through anti-inflammatory and antioxidant mechanisms. In conclusion, this study explored effective components in broad bean sprouts and performed in vitro evaluations.

蚕豆芽生物活性化合物治疗帕金森综合症的研究与体外评估
左旋多巴(LD)是最早发现的治疗帕金森病(PD)的药物,也是最有希望和最有效的药物。作为第一个被确认的左旋多巴天然来源,蚕豆(Vicia faba L.),尤其是蚕豆芽,已被证实含有许多其他潜在的生物活性化合物,也可用于治疗帕金森病。本研究筛选了从蚕豆芽提取物(BSE)中获得的有益于帕金森氏症治疗的生物活性成分,并探讨了相关机制。研究采用溶剂萃取结合柱层析的方法分离生物活性组分和单体化合物,并采用 UPLC-ESI-MS/MS、HRESI-MS 和 (1H, 13C) NMR 进行化合物鉴定。网络药理学技术用于筛选潜在的机制。在蚕豆芽的 50% MeOH 提取物中,共鉴定出 52 种化合物。此外,还从乙酸乙酯和正丁醇中分离鉴定出 12 种化合物,包括咖啡酸 (1)、反式-3-吲哚丙烯酸 (2)、对香豆素 (3)、原儿茶醛 (4)、异黄酮苷 (5)、异槲皮素 (6)、鹅掌楸碱 (7)、山柰酚-3-O-芸香糖苷 (8)、异皂角苷 (9)、水仙苷 (10)、山柰苷 (11) 和盐酸三尖杉酯碱 (12)。化合物 2、4、7、8 和 12 是首次从紫花苜蓿中分离出来的。通过使用蛋白质-蛋白质相互作用(PPI)网络、基因本体(GO)分析和京都基因和基因组百科全书(KEGG)富集分析 557 个药物靶点、2334 个疾病靶点以及它们之间的 199 个交叉点,确定了潜在的机制。进一步的体外实验证实,咖啡酸(化合物 1)和对香豆酸(化合物 3)通过抗炎和抗氧化机制对 6-羟基多巴胺处理的 SH-SY5Y 细胞和脂多糖处理的 PC-12 细胞具有神经保护作用。总之,本研究探索了蚕豆芽中的有效成分,并进行了体外评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecules
Molecules 化学-有机化学
CiteScore
7.40
自引率
8.70%
发文量
7524
审稿时长
1.4 months
期刊介绍: Molecules (ISSN 1420-3049, CODEN: MOLEFW) is an open access journal of synthetic organic chemistry and natural product chemistry. All articles are peer-reviewed and published continously upon acceptance. Molecules is published by MDPI, Basel, Switzerland. Our aim is to encourage chemists to publish as much as possible their experimental detail, particularly synthetic procedures and characterization information. There is no restriction on the length of the experimental section. In addition, availability of compound samples is published and considered as important information. Authors are encouraged to register or deposit their chemical samples through the non-profit international organization Molecular Diversity Preservation International (MDPI). Molecules has been launched in 1996 to preserve and exploit molecular diversity of both, chemical information and chemical substances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信